StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
SkinBioTherapeutics Plc
LSE:SBTX.L
Sector
Location
Market Cap
USD 59.26 M
Share Price
USD 0.22
Avg Daily Volume
1,290,895
Change (1 day)
-0.81%
Change (1 year)
97.01%
Change (YTD)
-2.83%
SkinBioTherapeutics Plc Research and Development (R&D) Expenses for the year ending June 30, 2024: USD 712.48 K
SkinBioTherapeutics Plc Research and Development (R&D) Expenses is USD 712.48 K for the year ending June 30, 2024, a -39.68% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.
-
SkinBioTherapeutics Plc Research and Development (R&D) Expenses for the year ending June 30, 2023 was USD 1.18 M, a 12.63% change year over year.
-
SkinBioTherapeutics Plc Research and Development (R&D) Expenses for the year ending June 30, 2022 was USD 1.05 M, a 50.00% change year over year.
-
SkinBioTherapeutics Plc Research and Development (R&D) Expenses for the year ending June 30, 2021 was USD 699.18 K, a -11.23% change year over year.
-
SkinBioTherapeutics Plc Research and Development (R&D) Expenses for the year ending June 30, 2020 was USD 787.63 K, a -12.38% change year over year.
Competitors
Bayer AG
USD 31.10
BAYN.DE
-0.14
-0.44%
Roivant Sciences Ltd.
USD 10.97
ROIV
+0.03
0.27%
ALK-Abelló A/S
USD 29.32
ALK-B.CO
-0.32
-1.08%
PharmaResearch Co., Ltd.
USD 368.22
214450.KQ
+24.18
7.03%
Bloomage BioTechnology Corporation Limited
USD 7.09
688363.SS
-0.12
-1.71%
Almirall, S.A.
USD 12.51
ALM.MC
-0.06
-0.44%
Tarsus Pharmaceuticals, Inc.
USD 40.45
TARS
+0.46
1.15%
Johnson & Johnson
USD 155.56
JNJ
-0.36
-0.23%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Key Data
| Date | Research and Development (R&D) Expenses | Revenue | Revenue | Gross Profit |
|---|
Competitors
Bayer AG
USD 31.10
BAYN.DE
-0.14
-0.44%
Roivant Sciences Ltd.
USD 10.97
ROIV
+0.03
0.27%
ALK-Abelló A/S
USD 29.32
ALK-B.CO
-0.32
-1.08%
PharmaResearch Co., Ltd.
USD 368.22
214450.KQ
+24.18
7.03%
Bloomage BioTechnology Corporation Limited
USD 7.09
688363.SS
-0.12
-1.71%
Almirall, S.A.
USD 12.51
ALM.MC
-0.06
-0.44%
Tarsus Pharmaceuticals, Inc.
USD 40.45
TARS
+0.46
1.15%
Johnson & Johnson
USD 155.56
JNJ
-0.36
-0.23%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%